279 related articles for article (PubMed ID: 16674938)
1. PPARgamma agonist induced cardiac enlargement is associated with reduced fatty acid and increased glucose utilization in myocardium of Wistar rats.
Edgley AJ; Thalén PG; Dahllöf B; Lanne B; Ljung B; Oakes ND
Eur J Pharmacol; 2006 May; 538(1-3):195-206. PubMed ID: 16674938
[TBL] [Abstract][Full Text] [Related]
2. Partial A1 adenosine receptor agonist regulates cardiac substrate utilization in insulin-resistant rats in vivo.
Shearer J; Severson DL; Su L; Belardinelli L; Dhalla AK
J Pharmacol Exp Ther; 2009 Jan; 328(1):306-11. PubMed ID: 18952888
[TBL] [Abstract][Full Text] [Related]
3. Cardiac metabolism in mice: tracer method developments and in vivo application revealing profound metabolic inflexibility in diabetes.
Oakes ND; Thalén P; Aasum E; Edgley A; Larsen T; Furler SM; Ljung B; Severson D
Am J Physiol Endocrinol Metab; 2006 May; 290(5):E870-81. PubMed ID: 16352676
[TBL] [Abstract][Full Text] [Related]
4. S26948, a new specific peroxisome proliferator activated receptor gamma modulator improved in vivo hepatic insulin sensitivity in 48 h lipid infused rats.
Sohn KA; Cruciani-Guglielmacci C; Kassis N; Clément L; Ouali F; Caüzac M; Lebègue N; Berthelot P; Caignard DH; Pégorier JP; Renard P; Dacquet C; Ktorza A; Magnan C;
Eur J Pharmacol; 2009 Apr; 608(1-3):104-11. PubMed ID: 19250932
[TBL] [Abstract][Full Text] [Related]
5. Berberine improves free-fatty-acid-induced insulin resistance in L6 myotubes through inhibiting peroxisome proliferator-activated receptor gamma and fatty acid transferase expressions.
Chen Y; Li Y; Wang Y; Wen Y; Sun C
Metabolism; 2009 Dec; 58(12):1694-702. PubMed ID: 19767038
[TBL] [Abstract][Full Text] [Related]
6. Pioglitazone induces lipid accumulation in the rat heart despite concomitant reduction in plasma free fatty acid availability.
Baranowski M; Blachnio-Zabielska A; Zabielski P; Gorski J
Arch Biochem Biophys; 2008 Sep; 477(1):86-91. PubMed ID: 18541139
[TBL] [Abstract][Full Text] [Related]
7. Metabolic action of peroxisome proliferator-activated receptor gamma agonism in rats with exogenous hypercorticosteronemia.
Berthiaume M; Laplante M; Tchernof A; Deshaies Y
Int J Obes (Lond); 2007 Nov; 31(11):1660-70. PubMed ID: 17579631
[TBL] [Abstract][Full Text] [Related]
8. Dissociation of antihyperglycaemic and adverse effects of partial perioxisome proliferator-activated receptor (PPAR-gamma) agonist balaglitazone.
Larsen PJ; Lykkegaard K; Larsen LK; Fleckner J; Sauerberg P; Wassermann K; Wulff EM
Eur J Pharmacol; 2008 Oct; 596(1-3):173-9. PubMed ID: 18761337
[TBL] [Abstract][Full Text] [Related]
9. Fatty acid metabolism assessed by 125I-iodophenyl 9-methylpentadecanoic acid (9MPA) and expression of fatty acid utilization enzymes in volume-overloaded hearts.
Miyamoto T; Takeishi Y; Tazawa S; Inoue M; Aoyama T; Takahashi H; Arimoto T; Shishido T; Tomoike H; Kubota I
Eur J Clin Invest; 2004 Mar; 34(3):176-81. PubMed ID: 15025675
[TBL] [Abstract][Full Text] [Related]
10. High-fat diet prevents cardiac hypertrophy and improves contractile function in the hypertensive dahl salt-sensitive rat.
Okere IC; Chess DJ; McElfresh TA; Johnson J; Rennison J; Ernsberger P; Hoit BD; Chandler MP; Stanley WC
Clin Exp Pharmacol Physiol; 2005 Oct; 32(10):825-31. PubMed ID: 16173943
[TBL] [Abstract][Full Text] [Related]
11. Pioglitazone reverses down-regulation of cardiac PPARgamma expression in Zucker diabetic fatty rats.
Pelzer T; Jazbutyte V; Arias-Loza PA; Segerer S; Lichtenwald M; Law MP; Schäfers M; Ertl G; Neyses L
Biochem Biophys Res Commun; 2005 Apr; 329(2):726-32. PubMed ID: 15737646
[TBL] [Abstract][Full Text] [Related]
12. Chronic, in vivo, PPARalpha activation prevents lipid overload in rat liver induced by high fat feeding.
Wierzbicki M; Chabowski A; Zendzian-Piotrowska M; Harasim E; Górski J
Adv Med Sci; 2009; 54(1):59-65. PubMed ID: 19403437
[TBL] [Abstract][Full Text] [Related]
13. Effect of ginsam, a vinegar extract from Panax ginseng, on body weight and glucose homeostasis in an obese insulin-resistant rat model.
Lim S; Yoon JW; Choi SH; Cho BJ; Kim JT; Chang HS; Park HS; Park KS; Lee HK; Kim YB; Jang HC
Metabolism; 2009 Jan; 58(1):8-15. PubMed ID: 19059525
[TBL] [Abstract][Full Text] [Related]
14. FK-614, a selective peroxisome proliferator-activated receptor gamma agonist, improves peripheral glucose utilization while decreasing hepatic insulin extraction in alloxan-induced diabetic dogs.
Uchino H; Kim T; Lam TK; Yoshii H; Klement P; Williams W; Kawamori R; Giacca A
Metabolism; 2005 Sep; 54(9):1250-8. PubMed ID: 16125538
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor-alpha,gamma-agonist improves insulin sensitivity and prevents loss of left ventricular function in obese dyslipidemic mice.
Verreth W; Ganame J; Mertens A; Bernar H; Herregods MC; Holvoet P
Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):922-8. PubMed ID: 16456093
[TBL] [Abstract][Full Text] [Related]
16. Effects of phenformin and alpha-bromopalmitate on fatty acid and glucose oxidation in muscle.
Tutwiler GF
Res Commun Chem Pathol Pharmacol; 1978 Mar; 19(3):541-4. PubMed ID: 653108
[TBL] [Abstract][Full Text] [Related]
17. Effect of medium- and long-chain fatty acid diets on PPAR and SREBP-1 expression and glucose homeostasis in ACBP-overexpressing transgenic rats.
Oikari S; Ahtialansaari T; Huotari A; Kiehne K; Fölsch UR; Wolffram S; Jänne J; Alhonen L; Herzig KH
Acta Physiol (Oxf); 2008 Sep; 194(1):57-65. PubMed ID: 18394026
[TBL] [Abstract][Full Text] [Related]
18. Beneficial role of L-arginine in cardiac matrix remodelling in insulin resistant rats.
Monti LD; Galluccio E; Lucotti P; Setola E; Costa S; Fontana B; Oldani M; Merante D; Di Blasi P; Bosi E; Piatti PM
Eur J Clin Invest; 2008 Nov; 38(11):849-56. PubMed ID: 19021703
[TBL] [Abstract][Full Text] [Related]
19. Effects of the dimethyl ester on succinic acid on the hormonal and metabolic response to exercise in hereditarily diabetic starved rats.
Ladrière L; Malaisse WJ
Cell Biochem Funct; 2000 Sep; 18(3):153-60. PubMed ID: 10965352
[TBL] [Abstract][Full Text] [Related]
20. Mechanism by which a novel non-thiazolidinedione peroxisome proliferator-activated receptor gamma agonist, FK614, ameliorates insulin resistance in Zucker fatty rats.
Minoura H; Takeshita S; Kimura C; Hirosumi J; Takakura S; Kawamura I; Seki J; Manda T; Mutoh S
Diabetes Obes Metab; 2007 May; 9(3):369-78. PubMed ID: 17391165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
